UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HemoDownloader: Open source software utility to extract data from HemoCue HbA1c 501 devices in epidemiological studies of diabetes mellitus

PloS one, 2020-11, Vol.15 (11), p.e0242087-e0242087

2020

Volltextzugriff (PDF)

Reduction of response time by data placement reflecting co-occurrence structures in structured overlay networks

PloS one, 2018-10, Vol.13 (10), p.e0205757-e0205757

2018

Volltextzugriff (PDF)

Increasing quality of SMPS through proper design of a high-frequency transformer

International journal of power electronics, 2020, Vol.11 (4), p.541

2020

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-06, Vol.381 (9884), p.2167-2175

2013

Volltextzugriff (PDF)

Granulocyte Colony―Stimulating Factor in Patients With Acute Ischemic Stroke: Results of the AX200 for Ischemic Stroke Trial

Stroke (1970), 2013-10, Vol.44 (10), p.2681-2687

2013

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.416-426

2010

Volltextzugriff (PDF)

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

The New England journal of medicine, 2012-03, Vol.366 (11), p.1000-1009

2012

Volltextzugriff (PDF)

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Journal of neurology, neurosurgery and psychiatry, 2014-08, Vol.85 (8), p.851-858

2014

Volltextzugriff (PDF)

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Lancet neurology, 2014-05, Vol.13 (5), p.472-481

2014

Volltextzugriff (PDF)

Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study

Cephalalgia, 2010-08, Vol.30 (8), p.933-942

2010

Volltextzugriff (PDF)

Control imaging after blunt renal trauma in the adult patient - A single level 1 trauma center experience

European urology, 2021-06, Vol.79, p.S1228

2021

Volltextzugriff (PDF)

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Volltextzugriff (PDF)

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis

Annals of neurology, 2008-05, Vol.63 (5), p.611-620

2008

Volltextzugriff (PDF)

Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study

Journal of the American Heart Association, 2022-05, Vol.11 (9), p.e021490-e021490

2022

Volltextzugriff (PDF)

Management of vitreous floaters: an international survey the European VitreoRetinal Society Floaters study report

Eye (London), 2020-05, Vol.34 (5), p.825-834

2020

Volltextzugriff (PDF)

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

Movement disorders, 2009-03, Vol.24 (4), p.541-550

2009

Volltextzugriff (PDF)

Increasing quality of SMPS through proper design of a high-frequency transformer

International journal of power electronics, 2020, Vol.11 (4), p.541

2020

Volltextzugriff (PDF)

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis

Annals of neurology, 2011-01, Vol.69 (1), p.75-82

2011

Volltextzugriff (PDF)

Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin: A Randomized Controlled Trial

Stroke (1970), 2014-08, Vol.45 (8), p.2348-2353

2014

Volltextzugriff (PDF)

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

Archives of neurology (Chicago), 2012-10, Vol.69 (10), p.1259

2012

Volltextzugriff (PDF)

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Lancet neurology, 2015-12, Vol.14 (12), p.1161-1170

2015

Volltextzugriff (PDF)

Long‐term efficacy and tolerability of 4‐monthly versus yearly botulinum toxin type A treatment for lower‐limb spasticity in children with cerebral palsy

Developmental medicine and child neurology, 2009-06, Vol.51 (6), p.436-445

2009

Volltextzugriff (PDF)

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

European journal of neurology, 2013-01, Vol.20 (1), p.5-15

2013

Volltextzugriff (PDF)

Diffusion of Silicon in Fe--C Alloys in Chemicothermal Treatment

Russian metallurgy Metally, 1990-01 (1), p.189-192

1990

Volltextzugriff (PDF)

1 – 25 von 685

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(621)
Mit Volltextzugriff
(531)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HemoDownloader: Open source software utility to extract data from HemoCue HbA1c 501 devices in epidemiological studies of diabetes mellitus

Reduction of response time by data placement reflecting co-occurrence structures in structured overlay networks

Increasing quality of SMPS through proper design of a high-frequency transformer

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Granulocyte Colony―Stimulating Factor in Patients With Acute Ischemic Stroke: Results of the AX200 for Ischemic Stroke Trial

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial

Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study

Control imaging after blunt renal trauma in the adult patient - A single level 1 trauma center experience

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis

Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study

Management of vitreous floaters: an international survey the European VitreoRetinal Society Floaters study report

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

Increasing quality of SMPS through proper design of a high-frequency transformer

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis

Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin: A Randomized Controlled Trial

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial

Long‐term efficacy and tolerability of 4‐monthly versus yearly botulinum toxin type A treatment for lower‐limb spasticity in children with cerebral palsy

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

Diffusion of Silicon in Fe--C Alloys in Chemicothermal Treatment

Suchergebnisse filtern